Acid Sphingomyelinase Activation Requires Caspase-8 but Not P53 nor Reactive Oxygen Species during Fas-Induced Apoptosis in Human Glioma Cells
- 15 February 2002
- journal article
- Published by Elsevier in Experimental Cell Research
- Vol. 273 (2) , 157-168
- https://doi.org/10.1006/excr.2001.5437
Abstract
No abstract availableKeywords
Funding Information
- Japan Science and Technology Agency
- Ono Medical Research Foundation
- Naito Foundation
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 57 references indexed in Scilit:
- Ceramide Enables Fas to Cap and KillJournal of Biological Chemistry, 2001
- Natural Ceramide Reverses Fas Resistance of Acid Sphingomyelinase −− HepatocytesJournal of Biological Chemistry, 2001
- CD95 Signaling via Ceramide-rich Membrane RaftsJournal of Biological Chemistry, 2001
- Crm-A, bcl-2 and NDGA inhibit CD95L-induced apoptosis of malignant glioma cells at the level of caspase 8 processingCell Death & Differentiation, 1998
- Fas/CD95/Apo-I activates the acidic sphingomyelinase via CaspasesCell Death & Differentiation, 1998
- CPP32 inhibition prevents Fas‐induced ceramide generation and apoptosis in human cellsFEBS Letters, 1996
- FLICE, A Novel FADD-Homologous ICE/CED-3–like Protease, Is Recruited to the CD95 (Fas/APO-1) Death-Inducing Signaling ComplexCell, 1996
- No requirement of reactive oxygen intermediates in Fas‐mediated apoptosisFEBS Letters, 1994
- The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53Cell, 1993
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993